Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleDurability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsRalph A Defronzo